DNLI is currently covered by 15 analysts with an average price target of $34.33. This is a potential upside of $15.88 (86.07%) from yesterday's end of day stock price of $18.45.
Denali Therapeutics's activity chart (see below) currently has 206 price targets and 181 ratings on display. The stock rating distribution of DNLI is 100% BUY.
Analysts' price targets on this stock were met 33.76% of the time, taking 115.83 days on average.
Highest price target for DNLI is $42, Lowest price target is $24, average price target is $34.33.
Most recent stock forecast was given by MATTHEW HARRISON from MORGAN STANLEY on 13-Nov-2026. First documented stock forecast 02-Jan-2018.
Currently out of the existing stock ratings of DNLI, 34 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Jan-2018
$37
$18.55 (100.54%)
$42
9 days ago
(13-Nov-2026)
4/21 (19.05%)
$18.26 (97.44%)
299
Buy Since 08-May-2020
$24
$5.55 (30.08%)
$26
18 days ago
(04-Nov-2026)
15/22 (68.18%)
$3.04 (14.50%)
94
Buy Since 07-Jul-2025
$39
$20.55 (111.38%)
$39
18 days ago
(04-Nov-2026)
1/11 (9.09%)
$18.04 (86.07%)
40
Buy Since 06-Sep-2023
$35
$16.55 (89.70%)
$35
2 months 28 days ago
(25-Aug-2026)
0/7 (0%)
$10.07 (40.39%)
Buy Since 12-Dec-2023
$35
$16.55 (89.70%)
$31
4 months 6 days ago
(16-Jul-2026)
1/6 (16.67%)
$12.27 (53.98%)
208
What is DNLI (Denali Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on DNLI (Denali Therapeutics)?
Which analyst has the most public recommendations on DNLI (Denali Therapeutics)?
Which analyst is the currently most bullish on DNLI (Denali Therapeutics)?
Which analyst is the currently most reserved on DNLI (Denali Therapeutics)?